Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is one of the stocks under $1 that will explode. Sangamo Therapeutics, Inc.’s ...

Tango Therapeutics ( ($TNGX) ) has shared an announcement. On January 2, 2026, Tango Therapeutics, Inc. expanded its Board of Directors from seven ...

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic ...

Biopharmaceutical company Agomab Therapeutics filed for an initial public ‌offering in the United ​States on Friday.

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug Administration (FDA) ...

TG Therapeutics, Inc. (NASDAQ: TGTX) shares climbed in Tuesday’s extended trading after the company released its preliminary ...

"We are delighted to welcome Sung Lee to our Board of Directors," said Barbara Weber, M.D., Chief Executive Officer of Tango Therapeutics. "Sung’s proven track record in corporate strategy, investor ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) stock tumbled Wednesday after the FDA rejection for relacorilant. The commercial-stage company is engaged in the discovery and development of ...

Stoke Therapeutics advances TANGO ASO for Dravet, with Zorevunersen Phase 3 data showing seizure reduction and a delayed 2027 ...